Wednesday, February 10, 2010, 4:41pm SGT - The Singapore stock market closes in 19 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Amarin Corporation plc (AMRN)

At 4:56AM SGT: 1.08 USD   0.00 (0.00%)  
 MORE ON AMRN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Amarin Corporation PLC (NCM:AMRN) Delayed quote dataEdit
Last Trade:1.08 USD
Trade Time:4:56AM SGT
Change: 0.00 (0.00%)
Prev Close:1.08
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.95
Day's Range:N/A - N/A
52wk Range:0.46 - 2.25
Volume:0
Avg Vol (3m):36,442.9
Market Cap:105.24M
P/E (ttm):N/A
EPS (ttm):-1.06
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AMRN to Portfolio   Download Data

 HEADLINES 
•Amarin To Present at the 12th Annual BIO CEO & Investor Conference
PRNewswire (Tue, Feb 2)
•Amarin To Present at the 12th Annual BIO CEO & Investor Conference
PR Newswire (Tue, Feb 2)
•Amarin Provides 2009 Year-End Review to Shareholders
PRNewswire (Thu, Jan 28)
•Amarin Provides 2009 Year-End Review to Shareholders
PR Newswire (Thu, Jan 28)
•Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease
PRNewswire (Mon, Jan 11)
•Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 for the Treatment of Cardiovascular Disease
PR Newswire (Mon, Jan 11)
•Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Business Wire (Wed, Dec 2)
•Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Business Wire (Wed, Dec 2)
•Amarin Announces Notice of Annual General Meeting
Business Wire (Mon, Nov 23)
•AMARIN CORP PLC\UK Financials
EDGAR Online Financials (Tue, Oct 27)
More Headlines for AMRN...
 ANALYST 
EPS Est (next year) (Dec-08) :-0.87
EPS Est (in 2 years) (Dec-09) :-0.71
Avg Rec (current)*:4.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Amarin Corporation plc operates as a biopharmaceutical company with a focus on cardiovascular diseases. Its cardiovascular programs focus in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular d...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices